ARWR - Arrowhead Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Mar 2020)Next qtr. (Jun 2020)Current year (2020)Next year (2021)
No. of analysts991010
Avg. Estimate-0.11-0.04-0.27-0.62
Low estimate-0.16-0.33-0.81-1.31
High estimate0.010.571.20.66
Year ago EPS0.240.210.69-0.27
Revenue estimateCurrent qtr. (Mar 2020)Next qtr. (Jun 2020)Current year (2020)Next year (2021)
No. of analysts10101010
Avg. Estimate21.74M28.66M107.62M99.56M
Low estimate17.8MN/A54.45M40M
High estimate36M92.8M257.8M231M
Year ago salesN/AN/A168.8M107.62M
Sales growth (year/est)N/AN/A-36.20%-7.50%
Earnings history30/03/201929/06/201929/09/201930/12/2019
Est. EPS0.190.290.16-0.01
Actual EPS0.240.210.11-0.03
Difference0.05-0.08-0.05-0.02
Surprise %26.30%-27.60%-31.20%-200.00%
EPS trendCurrent qtr. (Mar 2020)Next qtr. (Jun 2020)Current year (2020)Next year (2021)
Current estimate-0.11-0.04-0.27-0.62
7 days ago-0.11-0.07-0.29-0.62
30 days ago-0.11-0.07-0.29-0.57
60 days ago-0.110-0.17-0.44
90 days ago-0.020-0.12-0.37
EPS revisionsCurrent qtr. (Mar 2020)Next qtr. (Jun 2020)Current year (2020)Next year (2021)
Up last 7 daysN/AN/A1N/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesARWRIndustrySectorS&P 500
Current qtr.-145.80%N/AN/A-0.34
Next qtr.-119.00%N/AN/A-0.12
Current year-139.10%N/AN/A-0.18
Next year-129.60%N/AN/A0.26
Next 5 years (per annum)7.33%N/AN/A0.04
Past 5 years (per annum)N/AN/AN/AN/A
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more